Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Shaun Pruitt headshot

Should Investors Buy Bristol Myers or CVS Stock Near 52-week Lows?

Investors are often on the lookout for strong companies that may be undervalued and present lucrative long-term opportunities.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed at $77.10 in the latest trading session, marking a +0.13% move from the prior day.

CVS Health (CVS) Down 14.5% Since Last Earnings Report: Can It Rebound?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS), backed by the announcement of entering into a colossal $10.6-billion acquisition agreement to purchase Oak Street Health.

Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The Zacks Analyst Blog Highlights Mastercard, Raytheon Technologies, BP, CVS Health and Uber Technologies

Mastercard, Raytheon Technologies, BP, CVS Health and Uber Technologies are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Mastercard, Raytheon Technologies & BP

Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), Raytheon Technologies Corporation (RTX) and BP p.l.c. (BP).

CVS Health's (CVS) New Acquisitions Aid, Cost Woes Linger

CVS Health (CVS) launches functionality that gives patients more choices and convenience in filling prescriptions.

Here's Why CVS Health (CVS) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CVS Health (CVS) Q4 Earnings Surpass Estimates, Margins Down

CVS Health's (CVS) Retail/LTC segment revenues rise on increased prescription and front store volume, pharmacy drug mix and brand inflation.

CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CVS Health (CVS) Q4 Earnings and Revenues Top Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 3.65% and 11.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Shaun Pruitt headshot

Time to Buy CVS Stock Before Crucial Q4 Earnings?

Trading near its 52-week lows and 23% from its highs, investors will be paying close attention to CVS Health's (CVS) fourth-quarter earnings on February 8.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $86.18 in the latest trading session, marking a -1.5% move from the prior day.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health (CVS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights Apple, Meta Platforms, Mastercard, CVS Health and Ameriprise Financial

Apple, Meta Platforms, Mastercard, CVS Health and Ameriprise Financial are included in this Analyst Blog.

Sheraz Mian headshot

Q4 Earnings Season Scorecard and Analyst Reports for Apple, Meta & Mastercard

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Meta Platforms, Inc. (META) and Mastercard Incorporated (MA).

Here's Why CVS Health (CVS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed at $87.78 in the latest trading session, marking a +0.14% move from the prior day.

CVS Health (CVS) to Report Q4 Earnings: What's in the Cards?

CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q4.

CVS Health (CVS) to Expand Health Care Access With New Pact

CVS Health's (CVS) recent collaboration establishes new Accountable Care that focuses on health equity, coordinated care and enhanced access.